STRIDES PHARMA SCIENCE Financial Statement Analysis
|
||
The Revenues of STRIDES PHARMA SCIENCE have increased by 17.36% YoY .
The Earnings Per Share (EPS) of STRIDES PHARMA SCIENCE has increased by Positive YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
STRIDES PHARMA SCIENCE Last 5 Annual Financial Results
[BOM: 532531|NSE : STAR]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹4,565 Cr | ₹3,890 Cr | ₹3,688 Cr | ₹3,070 Cr | ₹3,316 Cr |
Expenses | ₹3,768 Cr | ₹3,318 Cr | ₹3,303 Cr | ₹3,092 Cr | ₹2,689 Cr |
Operating Profit (Excl OI) | ₹798 Cr | ₹572 Cr | ₹385 Cr | ₹-22 Cr | ₹627 Cr |
Other Income | ₹64 Cr | ₹50 Cr | ₹135 Cr | ₹133 Cr | ₹59 Cr |
Interest | ₹249 Cr | ₹280 Cr | ₹261 Cr | ₹177 Cr | ₹150 Cr |
Depreciation | ₹192 Cr | ₹214 Cr | ₹243 Cr | ₹233 Cr | ₹206 Cr |
Profit Before Tax | ₹487 Cr | ₹-115 Cr | ₹-286 Cr | ₹-653 Cr | ₹275 Cr |
Profit After Tax | ₹409 Cr | ₹-144 Cr | ₹-231 Cr | ₹-474 Cr | ₹244 Cr |
Consolidated Net Profit | ₹3,593 Cr | ₹-71 Cr | ₹-203 Cr | ₹-460 Cr | ₹268 Cr |
Earnings Per Share (Rs) | ₹389.90 | ₹-7.68 | ₹-22.44 | ₹-51.25 | ₹29.93 |
PAT Margin (%) | 5.77 | -2.36 | -3.70 | -8.90 | 4.45 |
ROE(%) | 17.52 | -6.67 | -10.15 | -18.49 | 9.21 |
ROCE(%) | 16.56 | 3.47 | -0.49 | -9.49 | 9.08 |
Total Debt/Equity(x) | 0.70 | 1.14 | 1.27 | 1.18 | 0.76 |
Key Financials |
||
Market Cap | : | ₹ 8,094.2 Cr |
Revenue (TTM) | : | ₹ 4,632.7 Cr |
Net Profit(TTM) | : | ₹ 358.2 Cr |
EPS (TTM) | : | ₹ 38.8 |
P/E (TTM) | : | 22.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
STRIDES PHARMA SCIENCE | -4.3% | 5.7% | -6.5% |
SUN PHARMACEUTICAL INDUSTRIES | -1.3% | 1% | 7.9% |
DIVIS LABORATORIES | -3.2% | -0.3% | 48% |
CIPLA | -0.6% | -2.2% | -0.7% |
TORRENT PHARMACEUTICALS | 1.2% | 10.7% | 19.5% |
DR REDDYS LABORATORIES | -1.5% | -5.9% | -5.1% |
MANKIND PHARMA | 1.8% | 16.1% | 24.3% |
ZYDUS LIFESCIENCES | -1.3% | 0.4% | -15.3% |
LUPIN | -1.4% | -1.3% | 7.6% |
STRIDES PHARMA SCIENCE Revenues
[BOM: 532531|NSE : STAR]
Y-o-Y | 17.36 % |
5 Yr CAGR | 8.32 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹4,565 Cr | 17.36 | |
Mar2024 | ₹3,890 Cr | 5.47 | |
Mar2023 | ₹3,688 Cr | 20.13 | |
Mar2022 | ₹3,070 Cr | -7.41 | |
Mar2021 | ₹3,316 Cr | - |
STRIDES PHARMA SCIENCE Operating Profit
[BOM: 532531|NSE : STAR]
Y-o-Y | 39.41 % |
5 Yr CAGR | 6.21 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹798 Cr | 39.41 | |
Mar2024 | ₹572 Cr | 48.52 | |
Mar2023 | ₹385 Cr | Positive | |
Mar2022 | ₹-22 Cr | Negative | |
Mar2021 | ₹627 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 18.76 % |
5 Yr CAGR | -1.95 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 17.47% | 18.76 | |
Mar2024 | 14.71% | 40.77 | |
Mar2023 | 10.45% | Positive | |
Mar2022 | -0.7% | Negative | |
Mar2021 | 18.9% | - |
STRIDES PHARMA SCIENCE Profit After Tax
[BOM: 532531|NSE : STAR]
Y-o-Y | Positive |
5 Yr CAGR | 91.28 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹3,593 Cr | Positive | |
Mar2024 | ₹-71 Cr | Negative | |
Mar2023 | ₹-203 Cr | Negative | |
Mar2022 | ₹-460 Cr | Negative | |
Mar2021 | ₹268 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Positive |
5 Yr CAGR | 6.71 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 5.77 % | Positive | |
Mar2024 | -2.36 % | Negative | |
Mar2023 | -3.7 % | Negative | |
Mar2022 | -8.9 % | Negative | |
Mar2021 | 4.45 % | - |
STRIDES PHARMA SCIENCE Earnings Per Share (EPS)
[BOM: 532531|NSE : STAR]
Y-o-Y | Positive |
5 Yr CAGR | 89.98 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹390 | Positive | |
Mar2024 | ₹-7.68 | Negative | |
Mar2023 | ₹-22 | Negative | |
Mar2022 | ₹-51 | Negative | |
Mar2021 | ₹30 | - |
STRIDES PHARMA SCIENCE Return on Capital Employed (ROCE)
[BOM: 532531|NSE : STAR]
Y-o-Y | 377.23 % |
5 Yr CAGR | 16.21 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 16.56% | 377.23 | |
Mar2024 | 3.47% | Positive | |
Mar2023 | -0.49% | Negative | |
Mar2022 | -9.49% | Negative | |
Mar2021 | 9.08% | - |
STRIDES PHARMA SCIENCE Share Price vs Sensex
Current Share Price | : | ₹877.9 |
Current MarketCap | : | ₹ 8,094.2 Cr |
Updated EOD on | : | Jul 22,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
STRIDES PHARMA SCIENCE | -4.3% |
5.7% |
-6.5% |
SENSEX | -0.5% |
-0.3% |
1% |
STRIDES PHARMA SCIENCE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE SMALLCAP | -0.2% | 5.4% | 2.8% |
BSE HEALTHCARE | -1.4% | 3.8% | 15.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MICROCAP 250 | NA | 5.7% | 3.3% |
NIFTY TOTAL MARKET | -0.5% | 1.4% | 0.6% |
NIFTY MIDSMALL HEALTHCARE | -1.2% | 7.1% | 19.9% |
You may also like the below Video Courses
FAQ about STRIDES PHARMA SCIENCE Financials
How the annual revenues of STRIDES PHARMA SCIENCE have changed ?
The Revenues of STRIDES PHARMA SCIENCE have increased by 17.36% YoY .
How the Earnings per Share (EPS) of STRIDES PHARMA SCIENCE have changed?
The Earnings Per Share (EPS) of STRIDES PHARMA SCIENCE has increased by Positive YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs